ONE Bio Corp.
ONBI
$0.003
-$0.002-40.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Revenue | 53.91M | 53.87M | 53.21M | 52.30M | 50.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.91M | 53.87M | 53.21M | 52.30M | 50.80M |
| Cost of Revenue | 30.24M | 30.94M | 31.42M | 32.17M | 31.47M |
| Gross Profit | 23.67M | 22.93M | 21.79M | 20.13M | 19.33M |
| SG&A Expenses | 7.72M | 7.68M | 6.94M | 6.18M | 5.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 38.34M | 38.98M | 38.70M | 38.61M | 37.22M |
| Operating Income | 15.57M | 14.89M | 14.51M | 13.68M | 13.57M |
| Income Before Tax | 13.29M | 13.51M | 13.15M | 12.24M | 12.46M |
| Income Tax Expenses | 3.90M | 3.88M | 3.59M | 3.28M | 3.33M |
| Earnings from Continuing Operations | 9.39 | 9.63 | 9.56 | 8.96 | 9.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.00K | -109.00K | -119.30K | -278.60K | -527.80K |
| Net Income | 9.36M | 9.53M | 9.44M | 8.68M | 8.60M |
| EBIT | 15.57M | 14.89M | 14.51M | 13.68M | 13.57M |
| EBITDA | 16.43M | 15.61M | 15.17M | 14.27M | 14.20M |
| EPS Basic | 1.40 | 1.48 | 1.52 | 1.45 | 1.45 |
| Normalized Basic EPS | 1.30 | 1.29 | 1.31 | 1.23 | 1.22 |
| EPS Diluted | 1.32 | 1.39 | 1.40 | 1.30 | 1.31 |
| Normalized Diluted EPS | 1.22 | 1.21 | 1.20 | 1.11 | 1.11 |
| Average Basic Shares Outstanding | 27.34M | 25.86M | 24.87M | 23.99M | 23.78M |
| Average Diluted Shares Outstanding | 29.15M | 27.56M | 27.09M | 26.64M | 26.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.04% | -- | -- | -- | -- |